A multivariate Cox regression model that included age, gender, TNM, tumor grade and tumor histology as co-variants confirmed KRAS mutational status as a potential independent prognostic marker with a hazard ratio (HR) of 1.87 (95%CI 0.99–3.51, P = 0.05; Table 2). The gene discussed is KRAS; the disease is neoplasm.